Cost of disorders of the brain in Europe 2010

Gustavsson, Anders, Svensson, Mikael, Jacobi, Frank, Allgulander, Christer, Alonso, Jordi, Beghi, Ettore, Dodel, Richard, Ekman, Mattias +35 more·2011·European Neuropsychopharmacology

DOI 10.1016/j.euroneuro.2011.08.008

Cited by (1,008)

Items 401–500 of 1,008

Health, social and economic consequences of dementias: a comparative national cohort study
Siska Frahm‐Falkenberg, Rikke Ibsen, Jakob Kjellberg, Poul Jennum · 2016 · European Journal of Neurology
Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson’s Disease
Tânia Maria Bovolenta, Sonia Maria Cesar de Azevedo Silva Moura Magalhães Gomes, Roberta Arb Saba, Vanderci Borges, Henrique Ballalai Ferraz, Andre Carvalho Felicio · 2017 · Parkinson s Disease
The societal cost of treatment-seeking patients with borderline personality disorder in Germany
Till Wagner, Nele Assmann, Sandra Köhne, Anja Schaich, Daniel Alvarez‐Fischer, Stefan Borgwardt, Arnoud Roger Arntz, Ulrich Schweiger, Eva Faßbinder · 2021 · European Archives of Psychiatry and Clinical Neuroscience
Increasing value and reducing waste in stroke research
Berge, Eivind, Salman, Rustam Al-Shahi, van der Worp, H Bart, Stapf, Christian, Sandercock, Peter, Sprigg, Nikola, Macleod, Malcolm R, Kelly, Peter J, Nederkoorn, Paul J, Ford, Gary A et al. · 2017 · The Lancet Neurology
Evaluating the costs of adverse drug events in hospitalized patients: a systematic review
Maxime Durand, Christel Castelli, Clarisse Roux‐Marson, Jean‐Marie Kinowski, Géraldine Leguelinel · 2024 · Health Economics Review
Cost-of-Illness Studies for Bipolar Disorder: Systematic Review of International Studies
Huajie Jin, Paul McCrone · 2015 · PharmacoEconomics
Community-based implementation of trauma-focused interventions for youth: Economic impact of the learning collaborative model.
Alex R. Dopp, Rochelle F. Hanson, Benjamin E. Saunders, Clara Elizabeth Dismuke, Angela D. Moreland · 2017 · Psychological Services
The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient‐derived data
Alberto Raggi, Matilde Leonardi, Emanuela Sansone, Marcella Curone, Licia Grazzi, Domenico D’Amico · 2019 · European Journal of Neurology
Neuroinflammation in CNS diseases: Molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
Menizibeya Osain Welcome · 2020 · PharmaNutrition
Co-creation and regional adaptation of a resilience-based universal whole-school program in five European regions
Roxanna Morote, Carlota Las Hayas, Irantzu Izco-Basurko, Frederick Anyan, Ane Fullaondo, Valeria Donisi, Antoni Zwiefka, Dóra Guðrún Guðmundsdóttir, Mette Marie Ledertoug, Anna S. Ólafsdóttir et al. · 2020 · European Educational Research Journal
Clinically relevant drug interactions in anxiety disorders
Maria Rosaria Anna Muscatello, Edoardo Spina, Borwin Bandelow, David S. Baldwin · 2012 · Human Psychopharmacology Clinical and Experimental
Does Change in Cognitive Function Predict Change in Costs of Care for People With a Schizophrenia Diagnosis Following Cognitive Remediation Therapy?
Clare Reeder, Victoria Claire Harris, Andrew R. Pickles, Anita K. Patel, Matteo Cella, Til Wykes · 2014 · Schizophrenia Bulletin
Morbidity and mortality of childhood- and adolescent-onset epilepsy: A controlled national study
Poul Jennum, Line Pickering, Jakob Christensen, Rikke Ibsen, Jakob Kjellberg · 2016 · Epilepsy & Behavior
Serum calcium and risk of migraine: a Mendelian randomization study
Peter Yin, Verneri Anttila, Katherine M. Siewert, Aarno V. Palotie, George Davey Smith, Benjamin F. Voight · 2016 · Human Molecular Genetics
Adult‐onset brain tumors and neurodegeneration: Are polyphenols protective?
Tiziana Squillaro, Carla Schettino, Simone Sampaolo, Umberto Galderisi, Giuseppe Di Iorio, Antonio Giordano, Mariarosa Anna Beatrice Melone · 2017 · Journal of Cellular Physiology
Increasing Adiponergic System Activity as a Potential Treatment for Depressive Disorders
Douglas Affonso Formolo, Thomas Ho-yin Lee, Suk‐Yu Yau · 2019 · Molecular Neurobiology
Peptide based drug delivery systems to the brain
Yamir Islam, Andrew G. Leach, Jayden A. Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James R. Downing, Amos A. Fatokun, Meritxell Teixidò, Touraj Ehtezazi · 2020 · Nano Express
Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: a systematic review and meta-analysis
Shoji Yokobori, Tomoaki Yatabe, Yutaka Kondo, Kosaku Kinoshita, Yasuhiko Ajimi, Masaaki Iwase, Kyoko Unemoto, Junji Kumasawa, Jun Goto, Hitoshi Kobata et al. · 2020 · Journal of Intensive Care
Proof of Concept in Artificial-Intelligence-Based Wearable Gait Monitoring for Parkinson’s Disease Management Optimization
Robert Radu Ileșan, Claudia-Georgiana Cordoș, Laura-Ioana Mihăilă, Radu Fleșar, Ana-Sorina Popescu, Lăcrămioara Perju‐Dumbravă, Paul Faragó · 2022 · Biosensors
Preventing mental illness: closing the evidence-practice gap through workforce and services planning
Gareth Furber, Leonie Segal, Matthew Leach, Catherine Turnbull, Nicholas Gerard Procter, Mark Diamond, Stephanie Miller, Patrick D. McGorry · 2015 · BMC Health Services Research
Training models and status of clinical neuropsychologists in Europe: Results of a survey on 30 countries
Laura Hokkanen, Sandra Lettner, Fernando Barbosa, Marios Constantinou, Lauren A. Harper, Erich Kasten, Sara Mondini, Bertil Persson, Nataliya A. Varako, Erik Hessen · 2018 · The Clinical Neuropsychologist
Economic Burden in a German Cohort of Patients with Multiple Sclerosis
Jens Peter Reese, Axel John, Gabriele Wienemann, Anne Wellek, Norbert Sommer, Björn Tackenberg, Monika Balzer‐Geldsetzer, Richard C. Dodel · 2011 · European Neurology
The Use of Multiscale Molecular Simulations in Understanding a Relationship between the Structure and Function of Biological Systems of the Brain: The Application to Monoamine Oxidase Enzymes
Robert Vianello, Cármen Domene, Janez Mavri · 2016 · Frontiers in Neuroscience
Interventions for the management of obesity in people with bipolar disorder
Agnes Tully, Siobhán Smyth, Yvonne Conway, John Richard Geddes, Declan Devane, John P. Kelly, Fionnuala Jordan · 2020 · Cochrane Database of Systematic Reviews
Functioning mediates help-seeking for mental problems in the general population
Chantal Michel, Nina Schnyder, Stefanie J. Schmidt, Nicola Groth, BENNO GRAF SCHIMMELMANN, Frauke Schultze‐Lutter · 2018 · European Psychiatry
Cohort profile: the Brain and Mind Centre Optymise cohort: tracking multidimensional outcomes in young people presenting for mental healthcare
Joanne Sarah Carpenter, Frank Iorfino, Shane P. M. Cross, Alissa Nichles, Natalia Zmicerevska, Jacob J. Crouse, Jake Robert Palmer, Alexis Estelle Whitton, Django White, Sharon Linda Naismith et al. · 2020 · BMJ Open
Occurrence, mortality and cost of brain disorders in Denmark: a population-based cohort study
Søren Viborg Vestergaard, Thomas Bøjer Rasmussen, Sandra Elkjær Stallknecht, Jens Olsen, Niels Skipper, Henrik Toft Sørensen, Christian Fynbo Christiansen · 2020 · BMJ Open
Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands
Korinna Karampampa, Anders Gustavsson, E.Th.L. van Munster, Raymond Hupperts, Evert A. C. M. Sanders, Jop P. Mostert, Okke L. G. F. Sinnige, J de Graaf, Paul Pop, Carolin Miltenburger et al. · 2013 · Journal of Medical Economics
CNS drug development in Europe — Past progress and future challenges
David Nutt, Jim Attridge · 2013 · Neurobiology of Disease
Lack of orthostatic symptoms in dementia patients with orthostatic hypotension
Marie E. Bengtsson-Lindberg, Victoria Larsson, Lennart Minthon, Carina Wattmo, Elisabet Londos · 2014 · Clinical Autonomic Research
Trajectories of functioning after remission from anxiety disorders: 2-year course and outcome predictors
Sorana C. Iancu, Neeltje M. Batelaan, Marjolein B. M. Zweekhorst, Joske Bunders, Dick J. Veltman, Brenda W.J.H. Penninx, Anton J.L.M. van Balkom · 2013 · Psychological Medicine
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
Alison Barry, Owen Cronin, Aisling Ryan, Brian J. Sweeney, Siew Mei Yap, Orna O’Toole, Andrew P. Allen, Gerard A. Clarke, Ken D. O’Halloran, Eric J. Downer · 2016 · Frontiers in Physiology
Automatic EEG Processing for the Early Diagnosis of Traumatic Brain Injury
Bruno Albert, Jingjing Zhang, Alexandre Noyvirt, Rossitza Setchi, Haldor Sjaaheim, Svetla Velikova, Frode Strisland · 2016 · Procedia Computer Science
Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data
Katharina Bode, Rolf Vogel, Jochen Walker, Christoph Bernhard Kröger · 2016 · The European Journal of Health Economics
Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study
Gordon Ward Fuller, Mónica Hernández Alava, David J. Pallot, Fiona Elizabeth Lecky, Mathew Stevenson, Belinda J. Gabbe · 2016 · Value in Health
Stellate ganglion block attenuates chronic stress induced depression in rats
Weiwei Wang, Weidong Shi, Hua Qian, Xijin Deng, Tong Wang, Wenzhi Li · 2017 · PLoS ONE
Factors affecting the utilization of mental health services among undergraduate students in a Nigerian University
Olasumbo Bilikisu Kukoyi, Edidiong Ndueso Orok, Funmilayo S. Oluwafemi, Tunrayo Oluwadare, Olawale Ignatius Oni, Toba D. Bamitale, Boluwaji Jaiyesimi, Tolulope Funmilola Ojo, Hannah Eze · 2022 · Heliyon
Development and Evaluation of a Smartphone-Based Chatbot Coach to Facilitate a Balanced Lifestyle in Individuals With Headaches (BalanceUP App): Randomized Controlled Trial
Ulrich, Sandra, Gantenbein, Andreas R, Zuber, Viktor, Von Wyl, Agnes, Kowatsch, Tobias, Künzli, Hansjörg · 2024 · Journal of Medical Internet Research
Costs explained by function rather than diagnosis—results from the SNAC Nordanstig elderly cohort in Sweden
C. Lindholm, Anders Gustavsson, Linus Jönsson, Anders B. Wimo · 2012 · International Journal of Geriatric Psychiatry
Wireless Optogenetic Nanonetworks for Brain Stimulation: Device Model and Charging Protocols
Stefanus Wirdatmadja, Michael Taynnan Barros, Yevgeni A. Koucheryavy, Josep Miquel Jornet, Sasitharan Balasubramaniam · 2017 · IEEE Transactions on NanoBioscience
Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
Andrea Marcellusi, Gianluca Fabiano, Raffaella Viti, Pier Cesare Francesa Morel, Giuseppe Nicolò, Alberto Siracusano, Francesco Saverio Mennini · 2018 · BMJ Open
Metabolic phenotyping of opioid and psychostimulant addiction: A novel approach for biomarker discovery and biochemical understanding of the disorder
Giorgia Caspani, Viktoria Sebők, Nowshin Sultana, Jonathan Richard Swann, Alexis Bailey · 2021 · British Journal of Pharmacology
Virtual Reality for Health Care Professionals During a Pandemic: A Pilot Program
Ivana T. Croghan, Ryan T. Hurt, Christopher A. Aakre, Shawn C. Fokken, Karen M. Fischer, Stephanie A. Lindeen, Darrell R. Schroeder, Ravindra Ganesh, Karthik Ghosh, Brent A. Bauer · 2022 · Journal of Primary Care & Community Health
Flies with Parkinson's disease
Roeland Vanhauwaert, Patrik Verstreken · 2015 · Experimental Neurology
The impact of cue learning, trait anxiety and genetic variation in the serotonin 1A receptor on contextual fear
Johanna M.P. Baas, Ivo Heitland · 2014 · International Journal of Psychophysiology
Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs
Daniela Tardito, Alessandra Mallei, Maurizio Popoli · 2012 · Expert Opinion on Investigational Drugs
Long-Term Cost-Effectiveness and Return-on-Investment of a Mindfulness-Based Worksite Intervention: Results of a Randomized Controlled Trial
van Dongen, Johanna M., van Berkel, Jantien, Boot, Cécile R.L., Bosmans, Judith E., Proper, Karin I., Bongers, Paulien M., van der Beek, Allard J., van Tulder, Maurits W., van Wier, Marieke F. · 2016 · Journal of Occupational & Environmental Medicine
The interplay of etiological knowledge and mental illness stigma on healthcare utilisation in the community: A structural equation model
Nina Schnyder, Chantal Michel, Radoslaw Panczak, Susann Ochsenbein, BG Schimmelmann, Frauke Schultze‐Lutter · 2018 · European Psychiatry
PARADISE 24: A Measure to Assess the Impact of Brain Disorders on People’s Lives
Alarcos Cieza, Carla Sabariego, Marta Anczewska, Carolina Saskia Ballert, Jerome Edmond Bickenbach, María Cabello, Ambra Mara Giovannetti, Teemu Kaskela, Blanca Mellor, Tuuli Pitkänen et al. · 2015 · PLoS ONE
Cost Burden of Post Stroke Condition in Nigeria: A Pilot Study
Bridget N Birabi, Kayode Israel Oke, Paul O. Dienye, Udoka Chris Okafor · 2012 · Global Journal of Health Science
Microdialysis Monitoring of CSF Parameters in Severe Traumatic Brain Injury Patients: A Novel Approach
Eric Peter Thelin, David Nelson, Per Hamid Ghatan, Bo‐Michael Bellander · 2014 · Frontiers in Neurology
Health, social and economic consequences of hypersomnia: a controlled national study from a national registry evaluating the societal effect on patients and their partners
Poul Jennum, Rikke Ibsen, Kirsten Avlund, Jakob Kjellberg · 2013 · The European Journal of Health Economics
Gender-specific associations between leisure-time physical activity and symptoms of anxiety: the HUNT study
Audun Brunes, Sigríður Lára Guðmundsdóttir, Liv Berit Augestad · 2014 · Social Psychiatry and Psychiatric Epidemiology
Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan
Chhian Hūi Lêng, Ming Hui Chou, Sheng‐Hsiang Lin, Yen Kuang Yang, Jung‐Der Wang · 2016 · Schizophrenia Research
A decision support system to follow up and diagnose primary headache patients using semantically enriched data
Gilles Vandewiele, Femke De Backere, Kiani Lannoye, Maarten Vanden Berghe, Olivier Janssens, Sofie Van Hoecke, Vincent Keereman, Koen Paemeleire, Femke Ongenae, Filip De Turck · 2018 · BMC Medical Informatics and Decision Making
Societal Costs of Schizophrenia in Denmark: A Nationwide Matched Controlled Study of Patients and Spouses Before and After Initial Diagnosis
Lene Halling Hastrup, Erik Hertel Simonsen, Rikke Ibsen, Jakob Kjellberg, Poul Jennum · 2019 · Schizophrenia Bulletin
Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
Peter James Goadsby, Luminita Constantin, Caty Ebel‐Bitoun, Iva Igracki Turudic, Simon Hitier, C. Amand-Bourdon, Andrew Stewart · 2021 · European Journal of Neurology
Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology
Michela Tinelli, Matilde Leonardi, Koen Paemeleire, Dimos Dimitrios Mitsikostas, Elena Ruiz de la Torre, Timothy J. Steiner · 2021 · The Journal of Headache and Pain
Risk and Protective Factors of Mental Health Conditions: Impact of Employment, Deprivation and Social Relationships
Beatriz Oliveros, Esteban Agulló Tomás, Luís-Javier Márquez-Álvarez · 2022 · International Journal of Environmental Research and Public Health
Grey-matter texture abnormalities and reduced hippocampal volume are distinguishing features of schizophrenia
Eugenia Radulescu, Balaji Ganeshan, Sukhwinder Singh Shergill, Nick Medford, Chris R. Chatwin, Robert C. Young, Hugo Critchley · 2014 · Psychiatry Research Neuroimaging
Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study
Le Han, Peer Carsten Tfelt‐Hansen, Axel Skytthe, Kirsten Ohm Kyvik, Jes Olesen · 2012 · BMJ Open
Magnetoencephalography in Stroke Recovery and Rehabilitation
Andrea Paggiaro, Niels Birbaumer, Marianna Cavinato, Cristina Turco, Emanuela Formaggio, Alessandra Del Felice, Stefano Masiero, Francesco Piccione · 2016 · Frontiers in Neurology
Celecoxib and omega-3 fatty acids alone and in combination with risperidone affect the behavior and brain biochemistry in amphetamine-induced model of schizophrenia
Alaa E. El‐Sisi, Samia Salem Sokar, Magda El‐Sayed El‐Sayad, Ehab Sayed Ramadan, Enass Youssef Osman · 2016 · Biomedicine & Pharmacotherapy
Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives
Giuliani, Daniela, Ottani, Alessandra, Neri, Laura, Zaffe, Davide, Grieco, Paolo, Jochem, Jerzy, Cavallini, Gian Maria, Catania, Anna, Guarini, Salvatore · 2017 · Progress in Neurobiology
Developmental Delays in Socio-Emotional Brain Functions in Persons with an Intellectual Disability: Impact on Treatment and Support
Tanja Sappok, Angela Hassiotis, Marco O. Bertelli, Isabel Dziobek, Paula Sophia Sterkenburg · 2022 · International Journal of Environmental Research and Public Health
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia
Marcin Kołaczkowski, Monika Marcinkowska, Adam Bucki, Joanna Śniecikowska, Maciej Pawłowski, Grzegorz Kazek, Agata Siwek, Magdalena Jastrzębska‐Więsek, Anna Partyka, A Wasik et al. · 2014 · European Journal of Medicinal Chemistry
The state of psychiatry in the Czech Republic
Cyril Höschl, Petr Winkler, Ondřej Pěč · 2012 · International Review of Psychiatry
Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives by Suzuki–Miyaura Cross‐Coupling Reactions
Marilena Petrera, Thomas Wein, Lars Allmendinger, Miriam Sindelar, Jörg Pabel, Georg C. Höfner, Klaus T. Wanner · 2015 · ChemMedChem
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
Roberto Gasparini, Paolo Landa, Daniela Amicizia, Giancarlo Icardi, Walter Ricciardi, Chiara de Waure, Elena Tànfani, Paolo Bonanni, Carlo Lucioni, Angela Testi et al. · 2016 · Human Vaccines & Immunotherapeutics
Days out of role due to common physical and mental conditions in Portugal: Results from the WHO World Mental Health Survey
Graça Cardoso, Miguel Xavier, Gemma Vilagut, Maria V. Petukhova, Jordi Alonso, Ronald C. Kessler, José Miguel Caldas‐de‐Almeida · 2017 · BJPsych Open
Universelle Prävention kindlicher Verhaltensstörungen durch Elterntrainings
Kurt Hahlweg, Wolfgang Schulz · 2018 · Zeitschrift für Klinische Psychologie und Psychotherapie
Anxiety Disorders in Patients With Somatic Diseases
Michaela Henning, Claudia Subič-Wrana, Jörg Wiltink, Manfred Elmar Beutel · 2020 · Psychosomatic Medicine
Longer-Term Outcomes of the Incredible Years Parenting Intervention
Geertjan J. Overbeek, Jolien van Aar, Bram Orobio de Castro, Walter Matthys, Joyce Weeland, Rabia R. Chhangur, Patty H. O. Leijten · 2020 · Prevention Science
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation
Francesco Calzaferri, Paloma Narros‐Fernández, Ricardo de Pascual, Antonio M. G. de Diego, Annette Nicke, Javier Egea, Antonio M. G. de Diego, Cristóbal de los Rı́os · 2021 · Journal of Medicinal Chemistry
Iron Metabolism Disorders for Cognitive Dysfunction After Mild Traumatic Brain Injury
Suna Huang, Li Su, Hua Feng, Yujie Chen · 2021 · Frontiers in Neuroscience
Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine
Peter Falkai, Andrea Schmitt, Christian P. Rosenbeiger, Isabel Maurus, Lisa Hattenkofer, Alkomiet Hasan, Berend Malchow, Pascale Heim-Ohmayer, Martin Halle, Melanie Heitkamp · 2021 · European Archives of Psychiatry and Clinical Neuroscience
Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology
Richter, Hartmut, Silvia Dombrowski, Hajo M. Hamer, Peyman Hadji, Karel Kostev · 2015 · PubMed Central
Welfare consequences for people with epilepsy and their partners: A matched nationwide study in Denmark
Poul Jennum, Anne Sabers, Jakob Christensen, Rikke Ibsen, Jakob Kjellberg · 2017 · Seizure
Delivering cognitive-behavioural family interventions for schizophrenia
Onwumere, Juliana, Grice, Sarah, Kuipers, Elizabeth · 2016 · Australian Psychologist
The association between traumatic brain injury and ADHD in a Canadian adult sample
Ilie, Gabriela, Vingilis, Evelyn R., Mann, Robert E., Hamilton, Hayley, Toplak, Maggie, Adlaf, Edward M., Kolla, Nathan, Ialomiteanu, Anca, van der Mass, Mark, Asbridge, Mark et al. · 2015 · Journal of Psychiatric Research
Adult attention deficit hyperactivity disorder: a comprehensive review
Ozge C. Amuk Williams, Sakshi Prasad, Amanda McCrary, Erica Jordan, Vishi Sachdeva, Sheryl Deva, Harendra Kumar, Jayati Mehta, Purushottam Neupane, Aditi Gupta · 2023 · Annals of Medicine and Surgery
Psychiatric Hospital Bed Numbers and Prison Population Sizes in 26 European Countries: A Critical Reconsideration of the Penrose Hypothesis
Victor Blüml, Thomas Waldhoer, Nestor D. Kapusta, Benjamin Vyssoki · 2015 · PLoS ONE
Caregiving for Patients in Vegetative and Minimally Conscious States: Perceived Burden as a Mediator in Caregivers’ Expression of Needs and Symptoms of Depression and Anxiety
Marco Pagani, Ambra Mara Giovannetti, Venusia Covelli, Davide Sattin, Matilde Leonardi · 2014 · Journal of Clinical Psychology in Medical Settings
Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
Ajay Kapur · 2020 · CNS Drugs
Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, Ondřej Soukup, Jan Korábečný · 2022 · Medicinal Research Reviews
Stroke: Working toward a Prioritized World Agenda
Vladimir Hachinski, Geoffrey Alan Donnan, Philip B. Gorelick, Werner Hacke, Steven C. Cramer, Markku Kaste, Marc Fisher, Michael Brainin, Alastair Mitchell Buchan, Eng H. Lo et al. · 2010 · Cerebrovascular Diseases
Bridging the Gaps Between Basic Science and Cognitive-Behavioral Treatments for Anxiety Disorders in Routine Care: Current Status and Future Demands
J. Richter, A. Pittig, Maike Hollandt, U. Lueken · 2017 · Zeitschrift für Psychologie
Excess costs of mental disorders by level of severity
Hannah König, Hans-Helmut König, Jürgen Gallinat, Martin Lambert, Anne Karow, Judith Peth, Holger Schulz, Alexander Konnopka · 2022 · Social Psychiatry and Psychiatric Epidemiology
Global Trends in the Incidence of Anxiety Disorders From 1990 to 2019: Joinpoint and Age-Period-Cohort Analysis Study
Huiru Cao, Yang Wu, Hui Yin, Yanqi Sun, Hui Yuan, Mengjun Tao · 2024 · JMIR Public Health and Surveillance
Epidemiology and burden of chronic insomnia disorder in Europe: an analysis of the 2020 National Health and Wellness Survey
François-Xavier Chalet, Emiliano Albanese, Carlos Egea, Jason Gordon Ellis, Luigi Ferini‐Strambi, Anna Heidbreder, Damien Léger, Kushal Modi, Charles M. Morin, Abisola Olopoenia · 2024 · Journal of Medical Economics
Evaluation of costs of epilepsy using an electronic practice management software in Germany
Anna Hiro Noda, Anke Hermsen, Ralf Berkenfeld, Dieter Dennig, Günther Endrass, Jens Kaltofen, Ali Safavi, Stephan Wiehler, Gunther Carl, Uwe Meier et al. · 2015 · Seizure
A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischaemic stroke
Heesoo Joo, Guijing Wang, Mary G. George · 2017 · Stroke and Vascular Neurology
Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age
Hanna Gyllensten, Michael Wiberg, Kristina A. E. Alexanderson, Anders Norlund, Emilie Friberg, Jan A. Hillert, Olivia Ernstsson, Petter Tinghög · 2017 · The European Journal of Health Economics
Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments
Tina Habota, Anca‐Larisa Sandu, Gordon D. Waiter, Christopher J. McNeil, J. Douglas Steele, Jennifer A. Macfarlane, Heather Clare Whalley, Ruth Valentine, Dawn Younie, Nichola Crouch et al. · 2019 · Wellcome Open Research
Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors
Danniel Pereira‐Figueiredo, Amary Nascimento, Marta C. Cunha-Rodrigues, Rafael Brito, Karin da Costa Calaza · 2021 · Cellular and Molecular Neurobiology
Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s disease
Daniela Giuliani, Maria Galantucci, Laura Neri, Fabrizio Canalini, Anita Calevro, Alessandra Bitto, Alessandra Ottani, Eleonora Vandini, Paola Sena, Maurizio Sandrini et al. · 2014 · European Journal of Pharmacology
Krankheitskosten der Borderline Persönlichkeitsstörung aus gesellschaftlicher Perspektive
T. Wagner, S. Roepke, P. Marschall, C. Stiglmayr, B. Renneberg, Dieter Gieb, Claudia Dambacher, Sara Matthies, H. Salbach-Andrae, S. Fleßa et al. · 2013 · Zeitschrift für Klinische Psychologie und Psychotherapie
Economic Evaluation of a Web-Based Guided Self-Help Intervention for Employees With Depressive Symptoms
Anna S. Geraedts, Johanna Maria van Dongen, Annet M. Kleiboer, Noortje M. Wiezer, Willem van Mechelen, Pim J. Cuijpers, Judith Ekkina Bosmans · 2015 · Journal of Occupational and Environmental Medicine
Facilitators and Barriers to Sustainable Employment After Spinal Cord Injury or Acquired Brain Injury: The Person's Perspective
Katarzyna Karcz, Barbara Schiffmann, Urban Schwegler, Stefan Staubli, Monika Elisabeth Finger · 2022 · Frontiers in Rehabilitation Sciences
Framing of scientific knowledge as a new category of health care research
Luis Salvador‐Carulla, Ana Fernández, Rosamond H. Madden, Sue Lukersmith, Ruth Colagiuri, Ghazal Torkfar, Joachim Peter Sturmberg · 2014 · Journal of Evaluation in Clinical Practice